Related references
Note: Only part of the references are listed.Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial
Ilad Alavi Darazam et al.
SCIENTIFIC REPORTS (2021)
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials
Young Joo Han et al.
THERANOSTICS (2021)
Immunopathogenesis and treatment of cytokine storm in COVID-19
Jae Seok Kim et al.
THERANOSTICS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations
Ola Caster et al.
DRUG SAFETY (2020)
Cardiac Events Associated With Chimeric Antigen Receptor T-Cells (CAR-T) A VigiBase Perspective
Joe-Elie Salem et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Richard T. Eastman et al.
ACS CENTRAL SCIENCE (2020)
The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Yosra A. Helmy et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 Myocardial Injury in Survivors
Daniel S. Knight et al.
CIRCULATION (2020)
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
Seong Woo Choi et al.
ANTIVIRAL RESEARCH (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
FDA Approval of Remdesivir - A Step in the Right Direction
Daniel Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characterization of Myocardial Injury in Patients With COVID-19
Gennaro Giustino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J. Brown et al.
ANTIVIRAL RESEARCH (2019)
Androgenic Effects on Ventricular Repolarization A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes
Joe-Elie Salem et al.
CIRCULATION (2019)
Cardiovascular Toxicities Associated With Ibrutinib
Joe-Elie Salem et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
Vincent Madelain et al.
NATURE COMMUNICATIONS (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Intracellular Metabolism of Nucleoside/Nucleotide Analogues: A Bottleneck to Reach Active Drugs on HIV Reverse Transcriptase
Andrea Varga et al.
CURRENT DRUG METABOLISM (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
G. Niklas Noren et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
VigiBase, the WHO Global ICSR Database System: Basic facts
Marie Lindquist
DRUG INFORMATION JOURNAL (2008)
The reporting odds ratio and its advantages over the proportional reporting ratio
KJ Rothman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Share Paper
